ResMed | RMD - Des Atouts

Prix De L'Action
219.85
Variation Quotidienne
0.34 0.15%
Mensuellement
-2.85%
Annuel
-6.80%
Q2 Prévisions
215.15




Des Atouts Changement Date
Ansell USD 3.33B 3.2M 2025-12
Artivion USD 884.8M 27.13M 2025-12
AtriCure USD 654.18M 18.74M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Cochlear AUD 2.79B 31.3M 2025-12
Cooper Companies USD 12.42B 29.4M 2025-12
CSL USD 37.9B 1.5B 2025-12
Dexcom USD 6.34B 1.16B 2025-12
Edwards Lifesciences USD 13.7B 425M 2025-12
Fisher Paykel Healthcare NZD 2.63B 80.5M 2025-12
Globus Medical USD 5.3B 207.12M 2025-12
Haemonetics USD 2.49B 48.73M 2025-12
Idexx Laboratories USD 3.35B 35.95M 2025-12
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
Intuitive Surgical USD 20.11B 347.7M 2026-03
Masimo USD 1.7B 118.6M 2025-12
Medtronic USD 91.48B 139M 2025-12
Philips EUR 26.94B 605M 2025-12
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.5B 195.02M 2025-12
Sigma Healthcare AUD 8.29B 6.91B 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Steris USD 10.59B 180.7M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03